CY614A - Cell strains - Google Patents

Cell strains

Info

Publication number
CY614A
CY614A CY61471A CY61471A CY614A CY 614 A CY614 A CY 614A CY 61471 A CY61471 A CY 61471A CY 61471 A CY61471 A CY 61471A CY 614 A CY614 A CY 614A
Authority
CY
Cyprus
Prior art keywords
cell strains
strains
cell
Prior art date
Application number
CY61471A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CY614A publication Critical patent/CY614A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CY61471A 1966-02-18 1971-10-05 Cell strains CY614A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB40225/66A GB1177635A (en) 1966-02-18 1966-02-18 Cell Stains.
GB4022566 1966-09-08

Publications (1)

Publication Number Publication Date
CY614A true CY614A (en) 1971-10-05

Family

ID=26241297

Family Applications (1)

Application Number Title Priority Date Filing Date
CY61471A CY614A (en) 1966-02-18 1971-10-05 Cell strains

Country Status (13)

Country Link
US (1) US3520972A (xx)
JP (1) JPS5341230B1 (xx)
BE (1) BE694243A (xx)
CH (1) CH504532A (xx)
CY (1) CY614A (xx)
DE (1) DE1617940C2 (xx)
DK (1) DK119472B (xx)
ES (1) ES336810A1 (xx)
FR (1) FR1570435A (xx)
GB (1) GB1177635A (xx)
IL (1) IL27418A (xx)
IT (1) IT983058B (xx)
NL (1) NL6702396A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1300391A (en) * 1969-08-22 1972-12-20 Nat Res Dev Cell lines and virus culture
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4086134A (en) * 1973-09-18 1978-04-25 University Of Glasgow Method for preparation of vaccine against feline leukemia
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
EP0011865B1 (en) * 1978-11-30 1982-05-19 The Wellcome Foundation Limited Feline infectious peritonitis vaccine and process for its preparation
ES486442A0 (es) * 1978-11-30 1980-12-16 Wellcome Found Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4303645A (en) * 1980-04-18 1981-12-01 Cornell Research Foundation, Inc. Modified living canine parvovirus vaccine
FR2520378A1 (fr) * 1982-01-28 1983-07-29 Vaillant Defresne Laboratoires Perfectionnements apportes aux procedes de preparations de suspensions de cellules fraiches stabilisees destinees a l'usage pharmaceutique, cosmetique ou alimentaire
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
US5112756A (en) * 1986-06-02 1992-05-12 Canadian Patents And Development Limited Continuous production of bovine Maedi-Visna-like viral antigens in Cf2Th cells
US11823378B2 (en) * 2019-12-20 2023-11-21 PAIGE.AI, Inc. Systems and methods for processing electronic images to detect contamination in specimen preparations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (xx) * 1962-11-27
US3423505A (en) * 1964-10-31 1969-01-21 Univ Toronto Rabies vaccine and process for preparation thereof
US3450598A (en) * 1965-08-24 1969-06-17 Flow Lab Method for cell propagation
FR1484638A (fr) * 1965-11-17 1967-06-16 Rhone Poulenc Sa Procédé de culture et d'inactivation d'un nouveau virus

Also Published As

Publication number Publication date
FR1570435A (xx) 1969-06-13
IT983058B (it) 1974-10-31
DE1617940A1 (de) 1970-09-10
NL6702396A (xx) 1967-08-21
ES336810A1 (es) 1968-01-01
CH504532A (de) 1971-03-15
JPS5341230B1 (xx) 1978-11-01
IL27418A (en) 1971-06-23
DK119472B (da) 1971-01-11
BE694243A (xx) 1967-08-17
US3520972A (en) 1970-07-21
DE1617940C2 (de) 1985-05-30
GB1177635A (en) 1970-01-14

Similar Documents

Publication Publication Date Title
JPS4739059B1 (en) Battery
GB1135155A (en) Electrode structure
IL27539A (en) Organic electrolyte cells
IL28071A (en) Electrolytic cell
GB1134468A (en) Electrochemical cell
CY614A (en) Cell strains
GB1134592A (en) Improved load cell
CA859275A (en) Battery
GB1122507A (en) Electrochemical cell
AU419537B2 (en) Electrolytic cell
MY7100148A (en) Cell strains
AU406668B2 (en) Cells strains
CA743083A (en) Electrolytic cell
CA728253A (en) Hydrogen-hydride cell
AU1784367A (en) Cells strains
AU408666B2 (en) Improved load cell
CA741079A (en) Load cell
CA741397A (en) Battery structure
AU405852B2 (en) Solar cell
AU418384B2 (en) Lead-acid cell
AU414302B2 (en) Batteries
AU2001667A (en) Improved load cell
AU407658B2 (en) Improved battery construction
AU407971B2 (en) Battery
CA746878A (en) Electrolytic cell